SCHEMBL3333534

SCHEMBL3333534

c1cc(C2CNCC23CCNC3)ccn1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.33
HPGD P15428 1/20 0.33
SLC6A2 P23975 4/20 0.32
SLC6A4 P31645 4/20 0.32
SLC6A3 Q01959 3/20 0.32
ALDH1A1 P00352 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C19 P33261 2/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
RECQL P46063 1/20 0.31
HTR2A P28223 2/20 0.30
MAPT P10636 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
DRD2 P14416 1/20 0.30
HTR2C P28335 1/20 0.30
CHRNB2 P17787 1/20 0.30
CHRNA4 P43681 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11888742 0.93 CYP2D6 (0.36) CYP2D6HPGDSLC6A2SLC6A4SLC6A3
SCHEMBL2303349 0.86 CYP2D6 (0.38) CYP2D6HPGDALDH1A1CYP3A4CYP2C19
SCHEMBL3333528 0.77 RECQL (0.34) CYP2D6HPGDSLC6A2SLC6A4ALDH1A1
SCHEMBL15571072 0.76 TAAR1 (0.39) HPGDALDH1A1CYP3A4CYP2C9HTR2A
SCHEMBL29077955 0.75 CYP2D6 (0.37) CYP2D6HPGDALDH1A1CYP3A4CYP2C19
SCHEMBL29077956 0.75 CYP2D6 (0.37) CYP2D6HPGDALDH1A1CYP3A4CYP2C19
Hydrochloric Acid SCHEMBL25431015 0.73 CYP2D6 (0.36) CYP2D6HPGDALDH1A1CYP3A4CYP2C19
SCHEMBL6025678 0.73 LIG1 (0.38) SLC6A2SLC6A4SLC6A3RECQLHTR2A
SCHEMBL6025232 0.73 LIG1 (0.38) SLC6A2SLC6A4SLC6A3RECQLHTR2A
SCHEMBL6024476 0.73 LIG1 (0.38) SLC6A2SLC6A4SLC6A3RECQLHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US claimed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152158-A1 Substituted Disulfonamide Compounds BDKRB1, BDKRB2, BRS3 CYP2D6 1247/4885HPGD 2320/4885SLC6A2 1031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.